§ 814.40. Time frames for reviewing a PMA.
139 words·~1 min read·
/us/cfr/t21/s§ 814.40·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Within 180 days after receipt of an application that is accepted for filing and to which the applicant does not submit a major amendment, FDA will review the PMA and, after receiving the report and recommendation of the appropriate FDA advisory committee, send the applicant an approval order under § 814.44(d), an approvable letter under § 814.44(e), a not approvable letter under § 814.44(f), or an order denying approval under § 814.45. The approvable letter and the not approvable letter will provide an opportunity for the applicant to amend or withdraw the application, or to consider the letter to be a denial of approval of the PMA under § 814.45 and to request administrative review under section 515 (d)(4) and
(g)of the act. [51 FR 26364, July 22, 1986, as amended at 87 FR 2045, Jan. 13, 2022]
Connections3 cite this
Cited by 3 sections
Citation graph
cites case law
§ 814.40
Time frames for reviewing a PMA.
Fed. Reg.×3
Cites 0Cited by 3 across 1 source